ClinicalTrials.govpublic full text
A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
chronic kidney diseases, anemia of chronic kidney disease, real world evidence study, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801637
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.